George C. Manuel

Array ( [id] => 3788126 [patent_doc_number] => 05840747 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-24 [patent_title] => 'Calcium channel antagonists' [patent_app_type] => 1 [patent_app_number] => 8/485406 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 4652 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/840/05840747.pdf [firstpage_image] =>[orig_patent_app_number] => 485406 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3772534 [patent_doc_number] => 05807833 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-15 [patent_title] => 'Hydroxyethyl starch and use thereof as an absorbable mechanical barrier and intracavity carrier device' [patent_app_type] => 1 [patent_app_number] => 8/482235 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18647 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/807/05807833.pdf [firstpage_image] =>[orig_patent_app_number] => 482235 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3967352 [patent_doc_number] => 05886039 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-23 [patent_title] => 'Method and composition for treating erectile dysfunction' [patent_app_type] => 1 [patent_app_number] => 8/485041 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2258 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/886/05886039.pdf [firstpage_image] =>[orig_patent_app_number] => 485041 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3657737 [patent_doc_number] => 05658900 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-08-19 [patent_title] => 'Application of carbamazepine and oxcarbazepine in the treatment of Parkinson\'s disease and parkinsonian syndromes' [patent_app_type] => 1 [patent_app_number] => 8/446735 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1257 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/658/05658900.pdf [firstpage_image] =>[orig_patent_app_number] => 446735 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4404572 [patent_doc_number] => 06228383 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-08 [patent_title] => 'Use of fatty acid esters as bioadhesive substances' [patent_app_type] => 1 [patent_app_number] => 8/462222 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 19246 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 113 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/228/06228383.pdf [firstpage_image] =>[orig_patent_app_number] => 462222 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3732914 [patent_doc_number] => 05665762 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-09 [patent_title] => 'Decontaminating clinical samples' [patent_app_type] => 1 [patent_app_number] => 8/462954 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 35 [patent_no_of_words] => 18947 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/665/05665762.pdf [firstpage_image] =>[orig_patent_app_number] => 462954 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3698548 [patent_doc_number] => 05677313 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-10-14 [patent_title] => 'Antipsychotic method' [patent_app_type] => 1 [patent_app_number] => 8/462931 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20286 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 693 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/677/05677313.pdf [firstpage_image] =>[orig_patent_app_number] => 462931 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4048707 [patent_doc_number] => 05968926 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-19 [patent_title] => 'Antipsychotic method' [patent_app_type] => 1 [patent_app_number] => 8/463615 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20070 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 723 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/968/05968926.pdf [firstpage_image] =>[orig_patent_app_number] => 463615 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3649555 [patent_doc_number] => 05637765 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-06-10 [patent_title] => 'Process for the preparation of fluorinated benzoic acids' [patent_app_type] => 1 [patent_app_number] => 8/462235 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6797 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 178 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/637/05637765.pdf [firstpage_image] =>[orig_patent_app_number] => 462235 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3694431 [patent_doc_number] => 05679686 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-10-21 [patent_title] => 'Antipsychotic method' [patent_app_type] => 1 [patent_app_number] => 8/465215 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20293 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 693 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/679/05679686.pdf [firstpage_image] =>[orig_patent_app_number] => 465215 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3843375 [patent_doc_number] => 05708030 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-01-13 [patent_title] => 'Substituted kynurenines and process for their preparation' [patent_app_type] => 1 [patent_app_number] => 8/463895 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4588 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/708/05708030.pdf [firstpage_image] =>[orig_patent_app_number] => 463895 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3519766 [patent_doc_number] => 05529997 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-06-25 [patent_title] => 'Carboxyalkyl tricyclic derivatives useful as inhibitors of enkephalinase and ace' [patent_app_type] => 1 [patent_app_number] => 8/459208 [patent_app_country] => US [patent_app_date] => 1995-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16861 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 257 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/529/05529997.pdf [firstpage_image] =>[orig_patent_app_number] => 459208 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3777653 [patent_doc_number] => 05779357 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-07-14 [patent_title] => 'Method and apparatus for the preparation of a medical solution' [patent_app_type] => 1 [patent_app_number] => 8/455319 [patent_app_country] => US [patent_app_date] => 1995-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2735 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 185 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/779/05779357.pdf [firstpage_image] =>[orig_patent_app_number] => 455319 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4238096 [patent_doc_number] => 06143782 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-07 [patent_title] => 'Anti-inflammatory and anti-asthma treatment with reduced side effects' [patent_app_type] => 1 [patent_app_number] => 8/456274 [patent_app_country] => US [patent_app_date] => 1995-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7292 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/143/06143782.pdf [firstpage_image] =>[orig_patent_app_number] => 456274 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3806298 [patent_doc_number] => 05830907 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-03 [patent_title] => 'Application of riluzole in the treatment of neurological lesions associated with trauma' [patent_app_type] => 1 [patent_app_number] => 8/424529 [patent_app_country] => US [patent_app_date] => 1995-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1790 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/830/05830907.pdf [firstpage_image] =>[orig_patent_app_number] => 424529 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3762393 [patent_doc_number] => 05852036 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-22 [patent_title] => 'Method for treating anxiety' [patent_app_type] => 1 [patent_app_number] => 8/448278 [patent_app_country] => US [patent_app_date] => 1995-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6288 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/852/05852036.pdf [firstpage_image] =>[orig_patent_app_number] => 448278 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3688424 [patent_doc_number] => 05643911 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-01 [patent_title] => 'Medicament for therapeutic and prophylactic treatment of diseases caused by smooth muscle cell hyperplasia' [patent_app_type] => 1 [patent_app_number] => 8/441743 [patent_app_country] => US [patent_app_date] => 1995-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3373 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/643/05643911.pdf [firstpage_image] =>[orig_patent_app_number] => 441743 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3519995 [patent_doc_number] => 05530013 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-06-25 [patent_title] => 'Venlafaxine in the inducement of cognition enhancement' [patent_app_type] => 1 [patent_app_number] => 8/442546 [patent_app_country] => US [patent_app_date] => 1995-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2907 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 203 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/530/05530013.pdf [firstpage_image] =>[orig_patent_app_number] => 442546 [rel_patent_id] =>[rel_patent_doc_number] =>)